933790-88-6

Basic information

• Product Name: ethyl 3,4-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-6-O-trityl-β-D-glucopyranoside
• Synonyms: ethyl 3,4-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-6-O-trityl-β-D-glucopyranoside
• CAS NO: 933790-88-6
• Molecular Weight: 803.932
• Mol File: 933790-88-6.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: ethyl 3,4-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-6-O-trityl-β-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3,4-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-6-O-trityl-β-D-glucopyranoside(933790-88-6)
• EPA Substance Registry System: ethyl 3,4-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-6-O-trityl-β-D-glucopyranoside(933790-88-6)

Safety Data

• Hazardous Substances Data: 933790-88-6(Hazardous Substances Data)

Upstream product

• 98-88-4 benzoyl chloride 
• 76-83-5 trityl chloride 
• 130539-43-4 ethyl 2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 

Downstream Products

• 933790-89-7 ethyl 3,4-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
• 1308293-04-0 ethyl 6-O-acetyl-3,4-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
• 932015-08-2 3-(benzyloxycarbonylamino)propyl-3,4-di-O-benzoyl-2-deoxy-2-phthalimido-β-D-glucopyranoside 
• 933790-98-8 6-O-(3,4-di-O-benzoyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-3,4-di-O-benzoyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl bromide 
• 932015-07-1 ethyl 6-O-(3,4-di-O-benzoyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-3,4-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 
• 932015-06-0 ethyl 6-O-(6-O-acetyl-3,4-di-O-benzoyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-3,4-di-O-benzoyl-2-deoxy-2-phthalimido-1-thio-β-D-glucopyranoside 

Relevant articles and documents

ANTIMICROBIAL VACCINE COMPOSITIONS

This invention is directed to antimicrobial vaccine compounds and compositions comprising oligosaccharide β-(1→6)- glucosamine groups having from 3 to 12 glucosamine units linked through a linker group to tetanus toxoid wherein the toxoid is primarily in

METHODS FOR PROVIDING CONTINUOUS THERAPY AGAINST PNAG COMPRISING MICROBES

Disclosed are antimicrobial vaccines comprising oligosaccharide β-(1→6)-glucosamine groups.

Comparison of the armed/disarmed building blocks of the D -gluco and d -glucosamino series in the context of chemoselective oligosaccharide synthesis

A very elegant Fraser-Reid armed-disarmed approach recently expanded to the building blocks of the superarmed and superdisarmed series shows very high utility in chemoselective oligosaccharide synthesis. Although a number of studies dedicated to the chemo